Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 7597596, 22 pages
https://doi.org/10.1155/2017/7597596
Review Article

Radix Bupleuri: A Review of Traditional Uses, Botany, Phytochemistry, Pharmacology, and Toxicology

1Gansu University of Chinese Medicine, Lanzhou 730000, China
2School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China

Correspondence should be addressed to Jian Ni; ten.362@mctjn

Received 14 February 2017; Accepted 20 April 2017; Published 16 May 2017

Academic Editor: Gail B. Mahady

Copyright © 2017 Fude Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Editorial Committee of Chinese Pharmacopoeia, Chinese Pharmacopoeia, Medical Science and Technology Press, Beijing, China, 2015 edition, 2015.
  2. Y. S. Wang, H. M. Chang, and P. P. H. But, Pharmacology and applications of Chinese, Material Medica World Scientific, Singapore, 1987.
  3. M. L. Ashour and M. Wink, “Genus Bupleurum: a review of its phytochemistry, pharmacology and modes of action,” The Journal of Pharmacy and Pharmacology, vol. 63, no. 3, pp. 305–321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. B. P. Bermejo, M. J. A. Martinez, A. M. S. Sen et al., “In vivo and in vitro antiinflammatory activity of saikosaponins,” Life Sciences, vol. 63, no. 13, pp. 1147–1156, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Ma, Y. Bao, S. Wang et al., “Anti-inflammation effects and potential mechanism of saikosaponins by regulating nicotinate and nicotinamide metabolism and arachidonic acid metabolism,” Inflammation, vol. 39, no. 4, pp. 1453–1461, 2016. View at Publisher · View at Google Scholar
  6. J. K. Su, Y. J. Lee, B. M. Kim et al., “Effect of Bupleuri Radix Extracts on the Toxicity of 5-Fluorouracil in HepG2 Hepatoma Cells and Normal Human Lymphocytes,” Basic & Clinical Pharmacology & Toxicology, vol. 103, no. 4, pp. 305–313, 2008. View at Google Scholar
  7. Y. Motoo and N. Sawabu, “Antitumor effects of saikosaponins, baicalin and baicalein on human hepatoma cell lines,” Cancer Letters, vol. 86, no. 1, pp. 91–95, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. M. S. Idris-Usman, “Antinociceptive and antipyretic properties of the pharmaceutical herbal preparation, Radix bupleuri in rats,” Journal of Medicinal Plants Research, vol. 4, no. 8, pp. 659–663, 2010. View at Google Scholar · View at Scopus
  9. Q. Zhou, S.-S. Wang, G. Yang, W. Zhao, and H.-L. Li, “Development and evaluation of a herbal formulation with anti-pathogenic activities and probiotics stimulatory effects,” Journal of Integrative Agriculture, vol. 15, no. 5, pp. 1103–1111, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Wen, H. F. Xu, and H. Hao, “In vitro anti-influenza A H1N1 effect of extract of Bupleuri Radix,” Immunopharmacology and Immunotoxicology, vol. 33, no. 3, pp. 433–437, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Yoshikawa, T. Murakami, K. Hirano, M. Inadzuki, K. Ninomiya, and H. Matsuda, “Scorzonerosides A, B and C, novel triterpene oligoglycosides with hepatoprotective effect from Chinese Bupleuri radix, the roots of Bupleurum scorzonerifolium Willd.,” Tetrahedron Letters, vol. 38, no. 42, pp. 7395–7398, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. Wang, H. Li, H. Xu et al., “Beneficial effect of Bupleurum polysaccharides on autoimmune disease induced by Campylobacter jejuni in BALB/c mice,” Journal of Ethnopharmacology, vol. 124, no. 3, pp. 481–487, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Abe, M. Sakaguchi, H. Konishi, T. Tani, and S. Arichi, “The effects of saikosaponins on biological membranes,” Planta Medica, vol. 34, no. 6, pp. 160–166, 1978. View at Publisher · View at Google Scholar · View at Scopus
  14. S. L. Pan, “Bupleurum species: scientific evaluation and clinical applications,” Tayloc and Trancis Group, FLa, USA, 2006. View at Google Scholar
  15. R.-T. Tian, P.-S. Xie, and H.-P. Liu, “Evaluation of traditional Chinese herbal medicine: Chaihu (Bupleuri Radix) by both high-performance liquid chromatographic and high-performance thin-layer chromatographic fingerprint and chemometric analysis,” Journal of Chromatography A, vol. 1216, no. 11, pp. 2150–2155, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Q. Huang, X. Zhang, Z. X. Xu, J. Su, and S. K. Yan, “Fast determination of saikosaponins in Bupleurum by rapid resolution liquid chromatography with evaporative light scattering detection,” Journal of Pharmaceutical & Biomedical Analysis, vol. 49, no. 4, pp. 1048–1055, 2009. View at Publisher · View at Google Scholar
  17. C. Sui, J.-H. Wei, S.-L. Chen, H.-Q. Chen, L. M. Dong, and C.-M. Yang, “Construction of a full-length enriched cDNA library and analysis of 3111 ESTs from roots of Bupleurum Chinense DC,” Botanical Studies, vol. 51, no. 1, pp. 7–16, 2010. View at Google Scholar · View at Scopus
  18. H. Xie, K.-K. Huo, Z. Chao, and S.-L. Pan, “Identification of crude drugs from Chinese medicinal plants of the genus Bupleurum using ribosomal DNA ITS sequences,” Planta Medica, vol. 75, no. 1, pp. 89–93, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. L.-M. Hsu, Y.-S. Huang, S.-H. Tsay, F.-Y. Chang, and S.-D. Lee, “Acute hepatitis induced by Chinese hepatoprotective herb, xiao-chai-hu-tang,” Journal of the Chinese Medical Association, vol. 69, no. 2, pp. 86–88, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. B. E. Van Wyk and M. Wink, Medicinal Plants of the World: An Illustrated Scientific Guide to Important Medicinal Plants and Their Uses, vol. 58, Timber Press, Portland, 1st edition, 2004.
  21. J. Y. Xiong, N. Zang, C. Y. Zhang et al., “Studies on the anti-depression effect of Xiaoyao Powder in mic,” Pharmacology and Clinics of Chinese Materia Medica, vol. 23, no. 1, pp. 3–5, 2007. View at Google Scholar
  22. Y. Zhou, Y. Ren, Z. Ma et al., “Identification and quantification of the major volatile constituents in antidepressant active fraction of xiaoyaosan by gas chromatography-mass spectrometry,” Journal of Ethnopharmacology, vol. 141, no. 1, pp. 187–192, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Gao, X. Zheng, Z. Li et al., “Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry,” Journal of Ethnopharmacology, vol. 137, no. 1, pp. 690–699, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. Editorial Board of Flora of China, Flora of China, Science Publishing House, Beijing, China, 1998.
  25. Y. Z. Wang and Y. Y. Zhang, “Determination of species of medical Bupleunum,” Chinese Pharmaceutical Journal, no. 1, pp. 3–8, 1994. View at Google Scholar
  26. S. L. Pan, Q. S. Shun, Q. M. Bo, and X. S. Bao, The coloured atlas of the medicinal plants from genus Bupleurum in China, Shanghai Scientific and Technical Literature Press, Shangha, 2002.
  27. M. H. Yen, C. C. Lin, C. H. Chuang, and S. Y. Liu, “Evaluation of root quality of Bupleurum species by TLC scanner and the liver protective effects of “xiao-chai-hu-tang,” Journal of Ethnopharmacology, vol. 34, no. 2-3, pp. 155–165, 1991. View at Publisher · View at Google Scholar · View at Scopus
  28. X.-Q. Li, Q.-T. Gao, X.-H. Chen, and K.-S. Bi, “High performance liquid chromatographic assay of saikosaponins from Radix Bupleuri in China,” Biological and Pharmaceutical Bulletin, vol. 28, no. 9, pp. 1736–1742, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. Q. Zhou, J. P. Hao, and K. Q. Gao, “Analysis on Saikosaponin of Sixteen Bupleurum chinense from Shanxi,” Natural Product Research & Development, vol. 24, no. 5, pp. 644–647, 2012. View at Google Scholar
  30. Y.-H. Tang, Y.-Y. Zhang, H.-Y. Zhu, and C.-G. Huang, “A high-performance liquid chromatographic method for saikosaponin a quantification in rat plasma,” Biomedical Chromatography, vol. 21, no. 5, pp. 458–462, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Zhang, Y. Zhao, H. Liang, L. Huang, Q. Zhang, and X. Zhi, “Simultaneous HPLC-ELSD determination of saikosaponins a, c, d, f in Radix Bupleuri,” Chinese Journal of Pharmaceutical Analysis, vol. 27, no. 8, pp. 1150–1153, 2007. View at Google Scholar
  32. R. Lucena, S. Cárdenas, and M. Valcárcel, “Evaporative light scattering detection: Trends in its analytical uses,” Analytical and Bioanalytical Chemistry, vol. 388, no. 8, pp. 1663–1672, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Bao, C. Li, H. Shen, and F. Nan, “Determination of saikosaponin derivatives in Radix bupleuri and in pharmaceuticals of the Chinese multiherb remedy Xiaochaihu-tang using liquid chromatographic tandem mass spectrometry,” Analytical Chemistry, vol. 76, no. 14, pp. 4208–4216, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. B.-C. Liau, S.-S. Hsiao, M.-R. Lee, T.-T. Jong, and S.-T. Chiang, “Quality control of Chinese medicinal preparations. LC/ESI(+)/MS/MS analyses of saikosaponins-a and -c as markers of Bupleuri radix samples,” Journal of Pharmaceutical and Biomedical Analysis, vol. 43, no. 3, pp. 1174–1178, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Chen, J. Wang, L. Yuan, L. Zhou, X. Jia, and X. Tan, “Interaction of the main components from the traditional chinese drug pair chaihu-shaoyao based on rat intestinal absorption,” Molecules, vol. 16, no. 11, pp. 9600–9610, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. X. Lin, L. Xue, H. Zhang, and C. Zhu, “Determination of saikosaponins a, c, and d in Bupleurum Chinese DC from different areas by capillary zone electrophoresis,” Analytical and Bioanalytical Chemistry, vol. 382, no. 7, pp. 1610–1615, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. A. M. Fernandez-Ocana, M. V. Gomez-Rodriguez, and A. Velasco-Negueruela, “In vivo antifungal activity of the essential oil of Bupleurum gibraltarium against Plasmopara halstedii in sunflower,” Journal of Agricultural & Food Chemistry, vol. 52, no. 21, pp. 6414–6417, 2004. View at Publisher · View at Google Scholar
  38. M. A. Ocete, S. Risco, A. Zarzuelo, and J. Jimenez, “Pharmacological activity of the essential oil of Bupleurum gibraltaricum: Anti-inflammatory activity and effects on isolated rat uteri,” Journal of Ethnopharmacology, vol. 25, no. 3, pp. 305–313, 1989. View at Publisher · View at Google Scholar · View at Scopus
  39. S. H. Liu, S. S. Lu, Y. L. Su, and Y. Guo, “Analysis of volatile compounds in Radix bupleuri injection by GC-MS-MS,” Chromatographia, vol. 74, no. 5-6, pp. 497–502, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. X. Li, Y. Jia, A. Song, X. Chen, and K. Bi, “Analysis of the essential oil from Radix Bupleuri using capillary gas chromatography,” Yakugaku Zasshi, vol. 125, no. 10, pp. 815–819, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Ushio and H. Abe, “The effects of saikosaponin on macrophage functions and lymphocyte proliferation,” Planta Medica, vol. 57, no. 6, pp. 511–514, 1991. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Ushio and H. Abe, “Inactivation of measles virus and herpes simplex virus by Saikosaponin d,” Planta Medica, vol. 58, no. 2, pp. 171–173, 1992. View at Publisher · View at Google Scholar · View at Scopus
  43. V. K. Wong, T. Li, B. Y. Law et al., “Saikosaponin-d, a novel SERCA inhibitor, induces autophagic cell death in apoptosis-defective cells,” Cell Death & Disease, vol. 4, no. 7, Article no. e720, 2012. View at Google Scholar
  44. H. Otsuka, “Separation and determination of saponins of bupleuri radix by droplet counter current chromatography (DCC),” Planta Medica, vol. 33, no. 2, pp. 152–159, 1978. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Matsuda, T. Murakami, K. Ninomiya, M. Inadzuki, and M. Yoshikawa, “New hepatoprotective saponins, bupleurosides III, VI, IX, and XIII, from Chinese Bupleuri Radix: Structure-requirements for the cytoprotective activity in primary cultured rat hepatocytes,” Bioorganic and Medicinal Chemistry Letters, vol. 7, no. 17, pp. 2193–2198, 1997. View at Publisher · View at Google Scholar · View at Scopus
  46. J.-K. Ding, H. Fujino, R. Kasai et al., “Chemical evaluation of Bupleurum species collected in Yunnan, China,” Chemical and Pharmaceutical Bulletin, vol. 34, no. 3, pp. 1158–1167, 1986. View at Publisher · View at Google Scholar · View at Scopus
  47. D. Q. Li, J. Wu, L. Y. Liu et al., “Cytotoxic triterpenoid glycosides (saikosaponins) from the roots of Bupleurum chinense,” Bioorganic & Medicinal Chemistry Letters, vol. 25, no. 18, pp. 3887–3892, 2015. View at Publisher · View at Google Scholar
  48. H. Seto, N. Otake, S. Q. Luo, F. G. Qian, and G. Y. Xu, “Studies on chemical constituents of Bupleurum genus. Part II. Isolation of triterpenoid glycosides (saikosaponins) from Bupleurum kunmingense and their chemical structures,” Agricultural & Biological Chemistry, vol. 50, no. 4, pp. 943–948, 1986. View at Google Scholar
  49. Y.-Y. Yang, Y.-Z. Tang, C.-L. Fan, H.-T. Luo, P.-R. Guo, and J.-X. Chen, “Identification and determination of the saikosaponins in Radix bupleuri by accelerated solvent extraction combined with rapid-resolution LC-MS,” Journal of Separation Science, vol. 33, no. 13, pp. 1933–1945, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Ishii, M. Nakamura, S. Seo, K. Tori, T. Tozyo, and Y. Yoshimura, “Isolation, characterization, and nuclear magnetic resonance spectra of new saponins from the roots of Bupleurum falcatum L.,” Chemical and Pharmaceutical Bulletin, vol. 28, no. 8, pp. 2367–2373, 1980. View at Publisher · View at Google Scholar · View at Scopus
  51. Q.-X. Liu, H. Liang, Y.-Y. Zhao, B. Wang, W.-X. Yang, and Y. Yu, “Saikosaponin v-1 from roots of Bupleurum chinense DC.,” Journal of Asian Natural Products Research, vol. 3, no. 2, pp. 139–144, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. Ogihara and M. Nose, “Novel cleavage of the glycosidic bond of saponins in alcoholic alkali metal solution containing a trace of water,” Journal of the Chemical Society, Chemical Communications, no. 18, p. 1417, 1986. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Lee, D.-H. Yang, J. H. Suh et al., “Species discrimination of Radix Bupleuri through the simultaneous determination of ten saikosaponins by high performance liquid chromatography with evaporative light scattering detection and electrospray ionization mass spectrometry,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 879, no. 32, pp. 3887–3895, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. K. Shimizu, S. Amagaya, and Y. Ogihara, “New derivatives of saikosaponins,” Chemical and Pharmaceutical Bulletin, vol. 33, no. 8, pp. 3349–3355, 1985. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Tundis, M. Bonesi, B. Deguin et al., “Cytotoxic activity and inhibitory effect on nitric oxide production of triterpene saponins from the roots of Physospermum verticillatum (Waldst & Kit) (Apiaceae),” Bioorganic and Medicinal Chemistry, vol. 17, no. 13, pp. 4542–4547, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Liu, Y. Fang, L. Yang, X. Qin, G. Du, and X. Gao, “A qualitative, and quantitative determination and pharmacokinetic study of four polyacetylenes from Radix Bupleuri by UPLC-PDA-MS,” Journal of Pharmaceutical and Biomedical Analysis, vol. 111, no. 1, pp. 257–265, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. H. Q. Huang, J. Su, X. Zhang, L. Shan, and W. D. Zhang, “Qualitative and quantitative determination of polyacetylenes in different Bupleurum species by high performance liquid chromatography with diode array detector and mass spectrometry,” Journal of Chromatography A, vol. 1218, no. 8, pp. 1131–1138, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. Q. C. Li, H. Liang, Y. J Bai et al., “The Chemical Constituents from the Roots of Bupleurum chinense DC,” Journal of Chinese Pharmaceutical Sciences, vol. 7, no. 3, pp. 98-99, 1997. View at Google Scholar
  59. H. Liang, Y. Y. Zhao, and R. Y. Zhang, “A new chromone glycoside from Bupleurum chinense,” Chinese Chemical Letters, vol. 9, no. 1, pp. 69-70, 1998. View at Google Scholar · View at Scopus
  60. H. Liang, Y. Zhao, Y. Cui, and Q. Liu, “Flavonoids from the roots of Bupleurum chinense DC,” Journal of Beijing Medical University, vol. 7, no. 3, pp. 98-99, 2000. View at Google Scholar
  61. L. Tan, Y. Y. Zhao, B. Wang et al., “New isoflavonoside from Bupleurum scorzonerifolium,” Chinese Chemical Letters, vol. 9, no. 1, pp. 71–73, 1998. View at Google Scholar · View at Scopus
  62. W.-L. Chang, L.-W. Chiu, J.-H. Lai, and H.-C. Lin, “Immunosuppressive flavones and lignans from Bupleurum scorzonerifolium,” Phytochemistry, vol. 64, no. 8, pp. 1375–1379, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Kobayashi, T. Tawara, T. Tsuchida, and H. Mitsuhashi, “Studies on the constituents of Umbelliferae plants. XVIII. Minor constituents of Bupleuri Radix: Occurrence of saikogenins, polyhydroxysterols, a trihydroxy C18 fatty acid, a lignan and a new chromone,” Chemical and Pharmaceutical Bulletin, vol. 38, no. 11, pp. 3169–3171, 1990. View at Publisher · View at Google Scholar · View at Scopus
  64. Q. C. Li, H. Liang, and Y. Y. Zhao, “The chemical constituents from the roots of bupleurum chinense,” Journal of Chinese Pharmaceutical Sciences, no. 6, pp. 165-166, 1997. View at Google Scholar
  65. X. Q. Li, A. H. Song, W. Li X, and K. S. Bi, “Analysis of the fatty acid from Bupleurum chinense DC in China by GC-MS and GC-FID,” Chemical & Pharmaceutical Bulletin, vol. 53, no. 12, pp. 1613–1617, 2006. View at Google Scholar
  66. J. Y. Xie, “Bupleurum chinense DC polysaccharides attenuates lipopolysaccharide-induced acute lung injury in mice,” Phytomedicine International Journal of Phytotherapy & Phytopharmacology, vol. 19, no. 2, pp. 130–137, 2012. View at Google Scholar
  67. J. Chun, A. Tosun, and Y. S. Kim, “Anti-inflammatory effect of corymbocoumarin from Seseli gummiferum subsp. corymbosum through suppression of NF-κB signaling pathway and induction of HO-1 expression in LPS-stimulated RAW 264.7 cells,” International Immunopharmacology, vol. 31, pp. 207–215, 2016. View at Publisher · View at Google Scholar · View at Scopus
  68. J. Zhu, C. Luo, P. Wang, Q. He, J. Zhou, and H. Peng, “Saikosaponin A mediates the inflammatory response by inhibiting the MAPK and NF-κB pathways in LPS-stimulated RAW 264.7 cells,” Experimental and Therapeutic Medicine, vol. 5, no. 5, pp. 1345–1350, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. Y. Fu, X. Hu, Y. Cao, Z. Zhang, and N. Zhang, “Saikosaponin a inhibits lipopolysaccharide-oxidative stress and inflammation in Human umbilical vein endothelial cells via preventing TLR4 translocation into lipid rafts,” Free Radical Biology and Medicine, no. 89, pp. 777–785, 2015. View at Publisher · View at Google Scholar · View at Scopus
  70. T. H. Lee, J. Chang, and B. M. Kim, “Saikosaponin C inhibits lipopolysaccharide-induced apoptosis by suppressing caspase-3 activation and subsequent degradation of focal adhesion kinase in human umbilical vein endothelial cells,” Biochemical and Biophysical Research Communications, vol. 445, no. 3, pp. 615–621, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Zhao, S. Li, H. Zhang et al., “Saikosaponin a protects against experimental sepsis via inhibition of NOD2-mediated NF-κB activation,” Experimental and Therapeutic Medicine, vol. 10, no. 2, pp. 823–827, 2015. View at Publisher · View at Google Scholar · View at Scopus
  72. Y. Kodama, L. Xiaochuan, C. Tsuchiya, Y. Ohizumi, M. Yoshida, and N. Nakahata, “Dual effect of saikogenin D: in vitro inhibition of prostaglandin E 2 production and elevation of intracellular free Ca2+ concentration in C6 rat glioma cells,” Planta Medica, vol. 69, no. 8, pp. 765–767, 2003. View at Publisher · View at Google Scholar · View at Scopus
  73. P. Li, H. Kawachi, T. Morioka et al., “Suppressive effects of Sairei-to on monoclonal antibody 1-22-3-induced glomerulonephritis: Analysis of effective components,” Pathology International, vol. 47, no. 7, pp. 430–435, 1997. View at Publisher · View at Google Scholar · View at Scopus
  74. Y. Chen, X. L. Zhou, and C. R. Xue, “Therapeutic effects and mechanisms of chaihushugan decoction in experimental chronic pancreatitis rats,” Chinese Journal of Surgery of Integrated Traditional & Western Medicine, no. 3, pp. 330–333, 2010. View at Google Scholar
  75. J. Liu, Z. Zhao, and C. R. Xue, “Effect of chaihu shugan pulvis on dysfunction of pancreatic exocrine secretion in patients with chronic pancreatitis,” Chinese Journal of Surgery of Integrated Traditional & Western Medicine, no. 16, pp. 275–277, 2010. View at Google Scholar
  76. G. B. Lenon, C. G. Li, C. C. Xue, F. C. K. Thien, and D. F. Story, “Inhibition of inducible nitric oxide production and iNOS protein expression in lipopolysaccharide-stimulated rat aorta and Raw 264.7 macrophages by ethanol extract of a Chinese herbal medicine formula (RCM-101) for allergic rhinitis,” Journal of Ethnopharmacology, vol. 116, no. 3, pp. 547–553, 2008. View at Publisher · View at Google Scholar · View at Scopus
  77. Y.-L. Cheng, W.-L. Chang, S.-C. Lee et al., “Acetone extract of Bupleurum scorzonerifolium inhibits proliferation of A549 human lung cancer cells via inducing apoptosis and suppressing telomerase activity,” Life Sciences, vol. 73, no. 18, pp. 2383–2394, 2003. View at Publisher · View at Google Scholar · View at Scopus
  78. Y.-L. Chen, S.-Z. Lin, W.-L. Chang, Y.-L. Cheng, and H.-J. Harn, “Requirement for ERK activation in acetone extract identified from Bupleurrum scorzonerifolium induced A549 tumor cell apoptosis and keratin 8 phosphorylation,” Life Sciences, vol. 76, no. 21, pp. 2409–2420, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. Y.-L. Cheng, S.-C. Lee, S.-Z. Lin et al., “Anti-proliferative activity of Bupleurum scrozonerifolium in A549 human lung cancer cells in vitro and in vivo,” Cancer Letters, vol. 222, no. 2, pp. 183–193, 2005. View at Publisher · View at Google Scholar · View at Scopus
  80. Y.-L. Hsu, P.-L. Kuo, T.-C. Weng, M.-H. Yen, L.-C. Chiang, and C.-C. Lin, “The antiproliferative activity of saponin-enriched fraction from Bupleurum kaoi is through Fas-dependent apoptotic pathway in human non-small cell lung cancer A549 cells,” Biological and Pharmaceutical Bulletin, vol. 27, no. 7, pp. 1112–1115, 2004. View at Publisher · View at Google Scholar · View at Scopus
  81. L.-C. Chiang, L. T. Ng, L.-T. Liu, D.-E. Shieh, and C.-C. Lin, “Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species,” Planta Medica, vol. 69, no. 8, pp. 705–709, 2003. View at Publisher · View at Google Scholar · View at Scopus
  82. H. L. Hou, S. X. He, Z. F. Zhu et al., ““The role of saikosaponin d in regulating HIF-1α/COX-2 signal transduction pathway in human hepatocellular carcinoma cells,” Journal of Xian Jiaotong University, vol. 32, pp. 80–84, 2011. View at Google Scholar
  83. S. Willimott, J. Barker, L. A. Jones, and E. I. Opara, “An in vitro based investigation of the cytotoxic effect of water extracts of the Chinese herbal remedy LD on cancer cells,” Chemistry Central Journal, vol. 3, no. 1, pp. 1–16, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. T. Kuroki, “Prospective study of chemoprevention of hepatocellular carcinoma with sho-saiko-to (TJ-9),” Cancer, vol. 76, no. 5, pp. 743–749, 1995. View at Publisher · View at Google Scholar · View at Scopus
  85. H. Y. Zhao, “Clinical observation of the treatment of primary liver cancer by using xiao-chai-hu decoction,” Journal of Traditional Chinese Medicine, no. 18, p. 32, 1995. View at Google Scholar
  86. K. Haranaka, N. Satomi, A. Sakurai, R. Haranaka, N. Okada, and M. Kobayashi, “Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs,” Cancer Immunology Immunotherapy, vol. 20, no. 1, pp. 1–5, 1985. View at Publisher · View at Google Scholar · View at Scopus
  87. J.-S. Chang, K.-C. Wang, H.-W. Liu, M.-C. Chen, L.-C. Chiang, and C.-C. Lin, “Sho-saiko-to (Xiao-Chai-Hu-Tang) and crude saikosaponins inhibit Hepatitis B virus in a stable HBV-producing cell line,” American Journal of Chinese Medicine, vol. 35, no. 2, pp. 341–351, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. F. Yin, R. Pan, R. Chen, and L. Hu, “Saikosaponins from Bupleurum chinense and inhibition of HBV DNA replication activity,” Natural Product Communications, vol. 3, no. 2, pp. 155–157, 2008. View at Google Scholar · View at Scopus
  89. P. W. Cheng, L. T. Ng, L. C. Chiang, and C. C. Lin, “Antiviral effects of saikosaponins on human coronavirus 229E in vitro,” Clinical & Experimental Pharmacology & Physiology, vol. 33, no. 7, pp. 612–616, 2006. View at Publisher · View at Google Scholar
  90. G. T. Jin, L. Bo, and S. R. Wang, “Experimental study on material basis, efficacy and mechanism of antipyretic effect of Bupleuri Radix,” Journal of Chengdu University of Traditional Chinese Medicine, no. 36, pp. 28–30, 2013. View at Google Scholar
  91. S.-L. Cao, E. Chen, Q.-Z. Zhang, and X.-G. Jiang, “A novel nasal delivery system of a Chinese traditional medicine, Radix bupleuri, based on the concept of ion-activated in situ gel,” Archives of Pharmacal Research, vol. 30, no. 8, pp. 1014–1019, 2007. View at Publisher · View at Google Scholar · View at Scopus
  92. Y. Xie, W. Lu, S. Cao, X. Jiang, M. Yin, and W. Tang, “Preparation of bupleurum nasal spray and evaluation on its safety and efficacy,” Chemical and Pharmaceutical Bulletin, vol. 54, no. 1, pp. 48–53, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. Y. Li, C. Xu, Q. Zhang, J. Y. Liu, and R. X. Tan, “In vitro anti-Helicobacter pylori action of 30 Chinese herbal medicines used to treat ulcer diseases,” Journal of Ethnopharmacology, vol. 98, no. 3, pp. 329–333, 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. Y. Kumazawa, T. Kawakita, H. Takimoto, and K. Nomoto, “Protective effect of saikosaponin a, saikosaponin d and saikogenin D against Pseudomonas aeruginosa infection in mice,” International Journal of Immunopharmacology, vol. 12, no. 5, pp. 531–537, 1990. View at Publisher · View at Google Scholar · View at Scopus
  95. X. M. Du, H. Xie, and Y. Kang, “The Pharmacological activity of chinese “chaihu”-the root of bupleurum species,” Sci Eval Clin Appl, no. 10, pp. 135–149, 2006. View at Google Scholar
  96. Z.-Y. Li, H.-M. Sun, J. Xing, X.-M. Qin, and G.-H. Du, “Chemical and biological comparison of raw and vinegar-baked Radix Bupleuri,” Journal of Ethnopharmacology, vol. 165, pp. 20–28, 2015. View at Publisher · View at Google Scholar · View at Scopus
  97. H. Abe, M. Sakaguchi, M. Yamada, S. Arichi, and S. Odashima, “Pharmacological actions of saikosaponins isolated from Bupleurum falcatum. I. Effects of saikosaponings on liver function,” Planta Medica, vol. 40, no. 4, pp. 366–372, 1980. View at Publisher · View at Google Scholar · View at Scopus
  98. H. Matsuda, T. Murakami, K. Ninomiya, M. Inadzuki, and M. Yoshikawa, “New hepatoprotective saponins, bupleurosides III, VI, IX, and XIII, from Chinese Bupleuri Radix: Structure-requirements for the cytoprotective activity in primary cultured rat hepatocytes,” Bioorganic & Medicinal Chemistry Letters, vol. 28, no. 52, pp. 2193–2198, 1997. View at Publisher · View at Google Scholar · View at Scopus
  99. X. H. Han, X. D. Gai, Y. J. Xue, and M. Chen, “Effects of the extracts from Bupleurum Chinese DC on intracelluar free calcium concentration and vincristine accumulation in human hepatoma BEL-7402 cells,” Tumor, no. 26, pp. 314–317, 2006. View at Google Scholar
  100. H. Abe, M. Sakaguchi, S. Odashima, and S. Arichi, “Protective effect of saikosaponin-d isolated from Bupleurum falcatum L. on CCl4-induced liver injury in the rat,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 320, no. 3, pp. 266–271, 1982. View at Publisher · View at Google Scholar · View at Scopus
  101. J. Fan, X. Li, P. Li et al., “Saikosaponin-d attenuates the development of liver fibrosis by preventing hepatocyte injury,” Biochemistry & Cell Biology, vol. 85, no. 2, pp. 189–195, 2007. View at Publisher · View at Google Scholar
  102. M. Yamakage, J.-I. Hattori, J.-I. Satoh, and A. Namiki, “Effects of the Chinese herbal medicines Bupleuri radix, Ginseng radix, and Zingiberis rhizoma on lymphatic vessel activity in rats,” American Journal of Chinese Medicine, vol. 34, no. 6, pp. 1063–1068, 2006. View at Publisher · View at Google Scholar · View at Scopus
  103. Y. Kumazawa, H. Takimoto, C. Nishimura, T. Kawakita, and K. Nomoto, “Activation of murine peritoneal macrophages by saikosaponin a, saikosaponin d and saikogenin d,” International Journal of Immunopharmacology, vol. 11, no. 1, pp. 21–28, 1989. View at Publisher · View at Google Scholar · View at Scopus
  104. M. Kato, M.-Y. Pu, K.-I. Isobe, T. Hattori, N. Yanagita, and I. Nakashima, “Cell type-oriented differential modulatory actions of saikosaponin-d on growth responses and DNA fragmentation of lymphocytes triggered by receptor-mediated and receptor-bypassed pathways,” Immunopharmacology, vol. 29, no. 3, pp. 207–213, 1995. View at Publisher · View at Google Scholar · View at Scopus
  105. M. Kato, M.-Y. Pu, K.-I. Isobe et al., “Characterization of the immunoregulatory action of saikosaponin-d,” Cellular Immunology, vol. 159, no. 1, pp. 15–25, 1994. View at Publisher · View at Google Scholar · View at Scopus
  106. V. K. W. Wong, H. Zhou, S. S. F. Cheung, T. Li, and L. Liu, “Mechanistic study of saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation,” Journal of Cellular Biochemistry, vol. 107, no. 2, pp. 303–315, 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. H. Yi, B. Long, X. Ye, L. Zhang, X. Liu, and C. Zhang, “Autophagy: A potential target for thyroid cancer therapy (Review),” Molecular and Clinical Oncology, vol. 2, no. 5, pp. 661–665, 2014. View at Publisher · View at Google Scholar
  108. N. Mizushima, “Autophagy: process and function,” Genes & Development, vol. 21, no. 22, pp. 2861–2873, 2007. View at Publisher · View at Google Scholar · View at Scopus
  109. D. C. Rubinsztein, P. Codogno, and B. Levine, “Autophagy modulation as a potential therapeutic target for diverse diseases,” Nature Reviews Drug Discovery, vol. 11, no. 9, pp. 709–730, 2012. View at Publisher · View at Google Scholar · View at Scopus
  110. Z. J. Yang, C. E. Chee, S. Huang, and F. A. Sinicrope, “The role of autophagy in cancer: therapeutic implications,” Molecular Cancer Therapeutics, vol. 10, no. 9, pp. 1533–1541, 2011. View at Publisher · View at Google Scholar · View at Scopus
  111. E.-L. Eskelinen, “The dual role of autophagy in cancer,” Current Opinion in Pharmacology, vol. 11, no. 4, pp. 294–300, 2011. View at Publisher · View at Google Scholar · View at Scopus
  112. O. Yamaguchi and K. Otsu, “Role of autophagy in aging,” Journal of Cardiovascular Pharmacology, vol. 60, no. 3, pp. 242–247, 2012. View at Publisher · View at Google Scholar · View at Scopus
  113. B. Y. Law, J. F. Mo, and V. K. Wong, “Autophagic effects of Chaihu (dried roots of Bupleurum Chinense DC or Bupleurum scorzoneraefolium WILD),” Chinese Medicine, vol. 9, no. 1, article 21, 2014. View at Publisher · View at Google Scholar
  114. Y. Cheng, Y. Huang, Y. Tian, L. Xu, G. Q. Liu, and Z. J. Zahng, “Assessment of the effects of Radix Bupleuri and vinegar-baked Radix Bupleuri on cytochrome 450 activity by a six-drug cocktail approach,” Chinese Journal of Natural Medicines, vol. 11, no. 3, pp. 302–308, 2013. View at Publisher · View at Google Scholar · View at Scopus
  115. X. Chen, T. Yu, Z. Chen, R. Zhao, and S. Mao, “Effect of saikosaponins and extracts of vinegar-baked Bupleuri Radix on the activity of β-glucuronidase,” Xenobiotica, vol. 44, no. 9, pp. 785–791, 2014. View at Publisher · View at Google Scholar · View at Scopus
  116. M. Ye, Y.-F. Bi, L. Ding, W.-W. Zhu, and W. Gao, “Saikosaponin a functions as anti-epileptic effect in pentylenetetrazol induced rats through inhibiting mTOR signaling pathway,” Biomedicine and Pharmacotherapy, vol. 81, pp. 281–287, 2016. View at Publisher · View at Google Scholar · View at Scopus
  117. D. He, H. Wang, L. Xu et al., “Saikosaponin-a Attenuates Oxidized LDL Uptake and Prompts Cholesterol Efflux in THP-1 Cells,” Journal of Cardiovascular Pharmacology, vol. 67, no. 6, pp. 510–518, 2016. View at Publisher · View at Google Scholar · View at Scopus
  118. K.-G. Shyu, S.-C. Tsai, B.-W. Wang, Y.-C. Liu, and C.-C. Lee, “Saikosaponin C induces endothelial cells growth, migration and capillary tube formation,” Life Sciences, vol. 76, no. 7, pp. 813–826, 2004. View at Publisher · View at Google Scholar · View at Scopus
  119. T. H. Lee, S. H. Park, M.-H. You, J.-H. Lim, S.-H. Min, and B. M. Kim, “A potential therapeutic effect of saikosaponin C as a novel dual-target anti-Alzheimer agent,” Journal of Neurochemistry, vol. 136, no. 6, pp. 1232–1245, 2016. View at Publisher · View at Google Scholar · View at Scopus
  120. S. Zhu, F. Ling, Q. Zhang et al., “Anthelmintic activity of saikosaponins a and d from radix bupleuri against Dactylogyrus spp. infecting goldfish,” Diseases of Aquatic Organisms, vol. 111, no. 2, pp. 177–182, 2014. View at Publisher · View at Google Scholar · View at Scopus
  121. S. C. Cui, Q. Z. Cao, and C. X. Su, “Analysis of 50 cases of drug-induced liver disease,” Journal of Capital Medicine University, vol. 20, pp. 296-297, 1999. View at Google Scholar
  122. D. C. H. Teo, P. S. L. Ng, S. H. Tan et al., “Drug-induced liver injury associated with Complementary and Alternative Medicine: A review of adverse event reports in an Asian community from 2009 to 2014,” BMC Complementary and Alternative Medicine, vol. 16, no. 1, pp. 1–11, 2016. View at Publisher · View at Google Scholar · View at Scopus
  123. S. Itoh, K. Marutani, T. Nishijima, S. Matsuo, and M. Itabashi, “Liver injuries induced by herbal medicine, Syo-saiko-to (xiao-chai-hu-tang),” Digestive Diseases and Sciences, vol. 40, no. 8, pp. 1845–1848, 1995. View at Publisher · View at Google Scholar · View at Scopus
  124. C.-H. Lee, J.-D. Wang, and P.-C. Chen, “Risk of Liver Injury Associated with Chinese Herbal Products Containing Radix bupleuri in 639, 779 Patients with Hepatitis B Virus Infection,” PLoS ONE, vol. 6, no. 1, Article ID e16064, 2011. View at Publisher · View at Google Scholar · View at Scopus
  125. R. Sun, L. Wang, Q. Yang, W. Huang, and L. L. Lv, “Acute toxicity of volatile oil from Bupleurum chinense in rats and mice,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 16, pp. 154–156, 2010. View at Google Scholar
  126. W. Huang, R. Sun, and Z. Zhang, ““Dose-time-toxicity” relationship study on hepatotoxicity caused by multiple dose of total Bupleurum saponin crude extracts to rats,” China Journal of Chinese Materia Medica, vol. 35, no. 35, pp. 3344–3347, 2010. View at Publisher · View at Google Scholar · View at Scopus
  127. L. Xu, R. Song, J.-X. Tian, Y. Tian, G.-Q. Liu, and Z.-J. Zhang, “Analysis of saikosaponins in rat plasma by anionic adducts-based liquid chromatography tandem mass spectrometry method,” Biomedical Chromatography, vol. 26, no. 7, pp. 808–815, 2012. View at Publisher · View at Google Scholar · View at Scopus
  128. L. Lin, B. Ni, H. Lin et al., “Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: a review,” Journal of Ethnopharmacology, vol. 159, pp. 158–183, 2015. View at Publisher · View at Google Scholar · View at Scopus